Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Acrotech Biopharma Inc.

Clinical trials sponsored by Acrotech Biopharma Inc., explained in plain language.

Now part of Aurobindo Pharma Limited AUROPHARMA NSE

Commercial-stage biopharma focused on oncology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1

Gene-Based dosing study aims to make cancer drug safer

Knowledge-focused Completed

This early-phase study tested the safety and drug levels of belinostat in 17 patients with advanced solid tumors or blood cancers that had not responded to prior treatments. Researchers grouped patients by their UGT1A1 gene type to see if genetic differences affect how the drug i…

Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:55 UTC